Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	SLK RPS6KA4 ATR RPS6KA5 STK26 MAP3K5 STK16 NEK4 STK10 TLK1 CSNK1D CSNK1E STK33 SYK PKN1 PKN2 MAP3K15 NME2 EIF2AK2	3.77e-10	446	141	19	GO:0004674
GeneOntologyMolecularFunction	protein serine kinase activity	SLK RPS6KA4 ATR RPS6KA5 STK26 MAP3K5 STK16 NEK4 STK10 TLK1 CSNK1D CSNK1E STK33 PKN1 PKN2 MAP3K15 EIF2AK2	8.15e-10	363	141	17	GO:0106310
GeneOntologyMolecularFunction	protein kinase activity	SLK RPS6KA4 ATR RPS6KA5 STK26 MAP3K5 STK16 NEK4 JAK1 JAK2 STK10 TLK1 CSNK1D CSNK1E STK33 SYK PKN1 PKN2 MAP3K15 NME2 EIF2AK2	1.47e-09	600	141	21	GO:0004672
GeneOntologyMolecularFunction	kinase activity	SLK RPS6KA4 ATR RPS6KA5 STK26 NME2P1 AK7 MAP3K5 STK16 NEK4 JAK1 JAK2 STK10 TLK1 CSNK1D CSNK1E STK33 SYK PKN1 PKN2 MAP3K15 NME2 EIF2AK2	4.02e-09	764	141	23	GO:0016301
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	SLK RPS6KA4 ATR RPS6KA5 STK26 MAP3K5 STK16 NEK4 JAK1 JAK2 STK10 TLK1 CSNK1D CSNK1E STK33 SYK PKN1 PKN2 MAP3K15 NME2 EIF2AK2	2.72e-08	709	141	21	GO:0016773
GeneOntologyMolecularFunction	histone kinase activity	SLK RPS6KA4 ATR RPS6KA5 JAK2 PKN1	3.69e-08	28	141	6	GO:0035173
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	SLK RPS6KA4 ATR RPS6KA5 STK26 NME2P1 AK7 MAP3K5 STK16 NEK4 JAK1 JAK2 STK10 TLK1 CSNK1D CSNK1E STK33 SYK PKN1 PKN2 MAP3K15 NME2 EIF2AK2	1.73e-07	938	141	23	GO:0016772
GeneOntologyMolecularFunction	histone H3 kinase activity	RPS6KA4 RPS6KA5 JAK2 PKN1	1.13e-06	12	141	4	GO:0140996
GeneOntologyMolecularFunction	non-membrane spanning protein tyrosine kinase activity	STK16 JAK1 JAK2 SYK EIF2AK2	1.78e-05	46	141	5	GO:0004715
GeneOntologyMolecularFunction	histone H3S28 kinase activity	RPS6KA4 RPS6KA5	1.48e-04	3	141	2	GO:0044022
GeneOntologyMolecularFunction	histone H3S10 kinase activity	RPS6KA4 RPS6KA5	2.94e-04	4	141	2	GO:0035175
GeneOntologyMolecularFunction	nucleoside diphosphate kinase activity	NME2P1 AK7 NME2	4.18e-04	21	141	3	GO:0004550
GeneOntologyMolecularFunction	protein tyrosine kinase activity	RPS6KA5 STK16 JAK1 JAK2 SYK EIF2AK2	5.80e-04	145	141	6	GO:0004713
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	ARHGAP36 TBC1D5 ADGRB3 CCDC88A ARHGEF10 PLEKHG3 TBC1D1 SYDE2 GPSM2 IQGAP3 USP6NL	9.61e-04	507	141	11	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	ARHGAP36 TBC1D5 ADGRB3 CCDC88A ARHGEF10 PLEKHG3 TBC1D1 SYDE2 GPSM2 IQGAP3 USP6NL	9.61e-04	507	141	11	GO:0030695
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH2 CCDC88A DNAH17	9.92e-04	28	141	3	GO:0051959
GeneOntologyMolecularFunction	lipase binding	APOB LRPAP1	1.02e-03	7	141	2	GO:0035473
GeneOntologyMolecularFunction	histone modifying activity	SLK RPS6KA4 ATR RPS6KA5 JAK2 NCOA1 PKN1	1.23e-03	229	141	7	GO:0140993
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor binding	APOB SACS LRPAP1	1.76e-03	34	141	3	GO:0050750
GeneOntologyMolecularFunction	growth hormone receptor binding	JAK1 JAK2	2.15e-03	10	141	2	GO:0005131
GeneOntologyCellularComponent	microtubule organizing center	CENPF IFT74 UBXN6 ANKRD62 TRIM43 SPAG9 CCDC141 TUBGCP6 NEK4 MAPRE3 CCDC88A ARHGEF10 CEP72 CSNK1D CEP112 CEP95 GPSM2 PKN2	3.93e-05	919	139	18	GO:0005815
GeneOntologyCellularComponent	perinuclear region of cytoplasm	SLK CENPF STK26 AGGF1 SPAG9 FAF1 CYFIP2 STK16 MAPRE3 BCAP31 CSNK1D KCNH2 STK33 PKN2 PLEC CDC5L NME2 EIF2AK2	4.85e-05	934	139	18	GO:0048471
GeneOntologyCellularComponent	centrosome	CENPF IFT74 UBXN6 ANKRD62 TRIM43 SPAG9 CCDC141 TUBGCP6 CCDC88A ARHGEF10 CEP72 CSNK1D CEP112 CEP95 GPSM2 PKN2	5.46e-05	770	139	16	GO:0005813
GeneOntologyCellularComponent	extrinsic component of organelle membrane	ATP6V1C1 AMPH ATR COQ6	1.89e-04	43	139	4	GO:0031312
GeneOntologyCellularComponent	extrinsic component of synaptic vesicle membrane	ATP6V1C1 AMPH ATR	5.94e-04	25	139	3	GO:0098850
GeneOntologyCellularComponent	motile cilium	PRAMEF10 IFT74 SPEF2 DNAH2 AK7 ADGB ROPN1L TTC29 DNAH17	6.28e-04	355	139	9	GO:0031514
HumanPheno	Abnormal sperm morphology	IFT74 SPEF2 DNAH2 AK7 CEP112 TTC29 DNAH17	1.59e-06	66	46	7	HP:0012864
HumanPheno	Abnormal germ cell morphology	IFT74 SPEF2 DNAH2 AK7 CEP112 TTC29 DNAH17	1.77e-06	67	46	7	HP:0012862
HumanPheno	Abnormal male germ cell morphology	IFT74 SPEF2 DNAH2 AK7 CEP112 TTC29 DNAH17	1.77e-06	67	46	7	HP:0012863
HumanPheno	Abnormal sperm tail morphology	IFT74 SPEF2 DNAH2 AK7 TTC29 DNAH17	1.84e-06	43	46	6	HP:0012868
HumanPheno	Reduced sperm motility	IFT74 SPEF2 DNAH2 AK7 CEP112 TTC29 DNAH17	2.16e-06	69	46	7	HP:0012207
HumanPheno	Absent sperm flagella	SPEF2 DNAH2 AK7 TTC29 DNAH17	4.04e-06	28	46	5	HP:0032558
HumanPheno	Coiled sperm flagella	SPEF2 DNAH2 AK7 TTC29 DNAH17	8.07e-06	32	46	5	HP:0032560
HumanPheno	Short sperm flagella	IFT74 DNAH2 AK7 TTC29 DNAH17	9.44e-06	33	46	5	HP:0032559
HumanPheno	Abnormal sperm motility	IFT74 SPEF2 DNAH2 AK7 CEP112 TTC29 DNAH17	6.43e-05	115	46	7	HP:0012206
HumanPheno	Abnormal sperm physiology	IFT74 SPEF2 DNAH2 AK7 CEP112 TTC29 DNAH17	6.43e-05	115	46	7	HP:0034809
Domain	Protein_kinase_ATP_BS	SLK RPS6KA4 RPS6KA5 STK26 MAP3K5 NEK4 JAK1 JAK2 STK10 TLK1 CSNK1D CSNK1E STK33 SYK PKN1 PKN2 MAP3K15 EIF2AK2	3.54e-10	379	137	18	IPR017441
Domain	PROTEIN_KINASE_ATP	SLK RPS6KA4 RPS6KA5 STK26 MAP3K5 STK16 NEK4 JAK1 JAK2 STK10 TLK1 CSNK1D CSNK1E STK33 SYK PKN1 PKN2 MAP3K15 EIF2AK2	1.11e-09	459	137	19	PS00107
Domain	Kinase-like_dom	SLK RPS6KA4 ATR RPS6KA5 STK26 MAP3K5 STK16 NEK4 JAK1 JAK2 STK10 TLK1 CSNK1D CSNK1E STK33 SYK PKN1 PKN2 MAP3K15 EIF2AK2	2.81e-09	542	137	20	IPR011009
Domain	Prot_kinase_dom	SLK RPS6KA4 RPS6KA5 STK26 MAP3K5 STK16 NEK4 JAK1 JAK2 STK10 TLK1 CSNK1D CSNK1E STK33 SYK PKN1 PKN2 MAP3K15 EIF2AK2	3.14e-09	489	137	19	IPR000719
Domain	PROTEIN_KINASE_DOM	SLK RPS6KA4 RPS6KA5 STK26 MAP3K5 STK16 NEK4 JAK1 JAK2 STK10 TLK1 CSNK1D CSNK1E STK33 SYK PKN1 PKN2 MAP3K15 EIF2AK2	3.58e-09	493	137	19	PS50011
Domain	PROTEIN_KINASE_ST	SLK RPS6KA4 RPS6KA5 STK26 MAP3K5 STK16 NEK4 STK10 TLK1 CSNK1D CSNK1E STK33 PKN1 PKN2 MAP3K15 EIF2AK2	1.01e-08	362	137	16	PS00108
Domain	Pkinase	SLK RPS6KA4 RPS6KA5 STK26 MAP3K5 STK16 NEK4 STK10 TLK1 CSNK1D CSNK1E STK33 PKN1 PKN2 MAP3K15 EIF2AK2	2.06e-08	381	137	16	PF00069
Domain	Ser/Thr_kinase_AS	SLK RPS6KA4 RPS6KA5 MAP3K5 STK16 NEK4 STK10 TLK1 CSNK1D CSNK1E STK33 PKN1 PKN2 MAP3K15 EIF2AK2	5.83e-08	357	137	15	IPR008271
Domain	S_TKc	SLK RPS6KA4 RPS6KA5 STK26 MAP3K5 STK16 NEK4 STK10 TLK1 CSNK1D STK33 PKN1 PKN2 MAP3K15 EIF2AK2	6.27e-08	359	137	15	SM00220
Domain	TPR_8	NAA15 IFIT5 TMTC4 GPSM2 TTC17	4.27e-05	53	137	5	PF13181
Domain	PKK	SLK STK10	5.34e-05	2	137	2	IPR022165
Domain	VPS39/TGF_beta_rcpt-assoc_1	VPS39 TGFBRAP1	5.34e-05	2	137	2	IPR019452
Domain	VPS39/TGF_beta_rcpt-assoc_2	VPS39 TGFBRAP1	5.34e-05	2	137	2	IPR019453
Domain	Vps39_2	VPS39 TGFBRAP1	5.34e-05	2	137	2	PF10367
Domain	Vps39_1	VPS39 TGFBRAP1	5.34e-05	2	137	2	PF10366
Domain	PKK	SLK STK10	5.34e-05	2	137	2	PF12474
Domain	-	NRDE2 NAA15 ATR IFIT5 TMTC4 TTC29 GPSM2 TTC17	1.46e-04	207	137	8	1.25.40.10
Domain	Pkinase_C	RPS6KA4 RPS6KA5 PKN1 PKN2	1.52e-04	37	137	4	IPR017892
Domain	DUF4071	MAP3K5 MAP3K15	1.59e-04	3	137	2	PF13281
Domain	DUF4071	MAP3K5 MAP3K15	1.59e-04	3	137	2	IPR025136
Domain	TPR_REGION	NAA15 DNAH2 IFIT5 TMTC4 TTC29 GPSM2 TTC17	2.17e-04	165	137	7	PS50293
Domain	TPR	NAA15 DNAH2 IFIT5 TMTC4 TTC29 GPSM2 TTC17	2.17e-04	165	137	7	PS50005
Domain	CH-domain	SPEF2 MAPRE3 CEP95 PLEC IQGAP3	2.26e-04	75	137	5	IPR001715
Domain	Pkinase_C	RPS6KA4 RPS6KA5 PKN1 PKN2	2.50e-04	42	137	4	PF00433
Domain	Tyr_kinase_non-rcpt_Jak/Tyk2	JAK1 JAK2	3.17e-04	4	137	2	IPR016251
Domain	TPR-like_helical_dom	NRDE2 NAA15 ATR IFIT5 TMTC4 TTC29 GPSM2 TTC17	3.27e-04	233	137	8	IPR011990
Domain	TPR	NAA15 IFIT5 TMTC4 TTC29 GPSM2 TTC17	3.79e-04	129	137	6	SM00028
Domain	TPR_repeat	NAA15 IFIT5 TMTC4 TTC29 GPSM2 TTC17	4.47e-04	133	137	6	IPR019734
Domain	TPR_2	NAA15 IFIT5 TMTC4 TTC17	4.91e-04	50	137	4	PF07719
Domain	TPR_2	NAA15 IFIT5 TMTC4 TTC17	4.91e-04	50	137	4	IPR013105
Domain	TPR_1	NAA15 IFIT5 TMTC4 GPSM2 TTC17	5.26e-04	90	137	5	IPR001440
Domain	TPR_1	NAA15 IFIT5 TMTC4 GPSM2 TTC17	5.26e-04	90	137	5	PF00515
Domain	-	PKN1 PKN2	5.26e-04	5	137	2	1.10.287.160
Domain	AGC-kinase_C	RPS6KA4 RPS6KA5 PKN1 PKN2	7.57e-04	56	137	4	IPR000961
Domain	AGC_KINASE_CTER	RPS6KA4 RPS6KA5 PKN1 PKN2	7.57e-04	56	137	4	PS51285
Domain	S_TK_X	RPS6KA4 RPS6KA5 PKN1 PKN2	7.57e-04	56	137	4	SM00133
Domain	Ribosomal_S6_kinase_II	RPS6KA4 RPS6KA5	7.86e-04	6	137	2	IPR016239
Domain	TPR-contain_dom	NAA15 IFIT5 TMTC4 TTC29 GPSM2 TTC17	8.41e-04	150	137	6	IPR013026
Domain	Hr1	PKN1 PKN2	1.09e-03	7	137	2	SM00742
Domain	CHCR	VPS39 TGFBRAP1	1.09e-03	7	137	2	PS50236
Domain	Spectrin_repeat	SPTA1 CCDC141 PLEC	1.23e-03	29	137	3	IPR002017
Domain	Clathrin_H-chain/VPS_repeat	VPS39 TGFBRAP1	1.45e-03	8	137	2	IPR000547
Domain	HR1	PKN1 PKN2	1.45e-03	8	137	2	PF02185
Domain	ZF_RING_2	RNF213 TRIM43 TRIM43B TRIM33 TRIM55 ANKIB1 ZNF598 OBI1	1.62e-03	298	137	8	PS50089
Domain	BBOX	TRIM43 TRIM43B TRIM33 TRIM55	1.66e-03	69	137	4	SM00336
Domain	-	MAPRE3 CEP95 PLEC IQGAP3	1.84e-03	71	137	4	1.10.418.10
Domain	-	TRIM43 TRIM43B TRIM33 TRIM55	1.84e-03	71	137	4	4.10.45.10
Domain	NDP_KINASES	NME2P1 NME2	1.86e-03	9	137	2	PS00469
Domain	RING	RNF213 TRIM43 TRIM43B TRIM33 TRIM55 ANKIB1 ZNF598 OBI1	1.87e-03	305	137	8	SM00184
Domain	CH	SPEF2 MAPRE3 PLEC IQGAP3	2.04e-03	73	137	4	PS50021
Domain	NDK	NME2P1 NME2	2.31e-03	10	137	2	SM00562
Domain	NDK	NME2P1 NME2	2.31e-03	10	137	2	PF00334
Domain	Adenylat/UMP-CMP_kin	SPEF2 AK7	2.31e-03	10	137	2	IPR000850
Domain	Znf_RING	RNF213 TRIM43 TRIM43B TRIM33 TRIM55 ANKIB1 ZNF598 OBI1	2.82e-03	326	137	8	IPR001841
Domain	ZF_BBOX	TRIM43 TRIM43B TRIM33 TRIM55	2.85e-03	80	137	4	PS50119
Domain	Znf_B-box	TRIM43 TRIM43B TRIM33 TRIM55	2.98e-03	81	137	4	IPR000315
Domain	UBX	UBXN6 FAF1	3.36e-03	12	137	2	SM00166
Domain	Nucleoside_diP_kinase	NME2P1 NME2	3.36e-03	12	137	2	IPR001564
Domain	UBX_dom	UBXN6 FAF1	3.95e-03	13	137	2	IPR001012
Domain	UBX	UBXN6 FAF1	3.95e-03	13	137	2	PF00789
Domain	UBX	UBXN6 FAF1	3.95e-03	13	137	2	PS50033
Domain	CNH	VPS39 TGFBRAP1	5.27e-03	15	137	2	PF00780
Domain	CNH	VPS39 TGFBRAP1	5.27e-03	15	137	2	PS50219
Domain	CNH_dom	VPS39 TGFBRAP1	5.27e-03	15	137	2	IPR001180
Domain	TBC	TBC1D5 TBC1D1 USP6NL	5.56e-03	49	137	3	SM00164
Domain	FERM_central	JAK1 JAK2 MYO15A	5.56e-03	49	137	3	IPR019748
Domain	FERM_domain	JAK1 JAK2 MYO15A	5.56e-03	49	137	3	IPR000299
Domain	ZF_RING_1	TRIM43 TRIM43B TRIM33 TRIM55 ANKIB1 ZNF598 OBI1	5.71e-03	291	137	7	PS00518
Domain	FERM_1	JAK1 JAK2 MYO15A	5.88e-03	50	137	3	PS00660
Domain	FERM_2	JAK1 JAK2 MYO15A	5.88e-03	50	137	3	PS00661
Domain	FERM_3	JAK1 JAK2 MYO15A	5.88e-03	50	137	3	PS50057
Domain	Band_41_domain	JAK1 JAK2 MYO15A	5.88e-03	50	137	3	IPR019749
Domain	B41	JAK1 JAK2 MYO15A	5.88e-03	50	137	3	SM00295
Domain	HEAT_type_2	PPP4R1 ATR	6.76e-03	17	137	2	IPR021133
Domain	RabGAP-TBC	TBC1D5 TBC1D1 USP6NL	6.92e-03	53	137	3	PF00566
Pathway	REACTOME_RHOA_GTPASE_CYCLE	SLK STK10 BCAP31 ARHGEF10 PLEKHG3 PKN1 PKN2 IQGAP3	5.05e-06	142	95	8	MM15576
Pathway	REACTOME_RHOB_GTPASE_CYCLE	SLK STK10 ARHGEF10 PKN1 PKN2 IQGAP3	6.80e-06	69	95	6	MM15596
Pathway	REACTOME_RHOA_GTPASE_CYCLE	SLK STK10 BCAP31 ARHGEF10 PLEKHG3 PKN1 PKN2 IQGAP3	7.22e-06	149	95	8	M41805
Pathway	REACTOME_RHOB_GTPASE_CYCLE	SLK STK10 ARHGEF10 PKN1 PKN2 IQGAP3	7.40e-06	70	95	6	M41806
Pathway	REACTOME_RHOC_GTPASE_CYCLE	SLK STK10 ARHGEF10 PKN1 PKN2 IQGAP3	7.40e-06	70	95	6	MM15597
Pathway	REACTOME_RHO_GTPASE_CYCLE	SLK TMOD3 ANKRD62 CYFIP2 STK10 BCAP31 CCDC88A ARHGEF10 PLEKHG3 SYDE2 PKN1 PKN2 IQGAP3	7.42e-06	439	95	13	MM15595
Pathway	REACTOME_RHOC_GTPASE_CYCLE	SLK STK10 ARHGEF10 PKN1 PKN2 IQGAP3	1.02e-05	74	95	6	M41807
Pathway	REACTOME_RHO_GTPASE_CYCLE	SLK TMOD3 CYFIP2 STK10 BCAP31 CCDC88A ARHGEF10 PLEKHG3 SYDE2 PKN1 PKN2 IQGAP3	4.79e-05	450	95	12	M27078
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	SLK CENPF TMOD3 ANKRD62 CYFIP2 STK10 BCAP31 CCDC88A ARHGEF10 PLEKHG3 SYDE2 PKN1 PKN2 IQGAP3	1.08e-04	649	95	14	MM15690
Pathway	REACTOME_RAC1_GTPASE_CYCLE	CYFIP2 ARHGEF10 PLEKHG3 SYDE2 PKN1 PKN2 IQGAP3	1.78e-04	175	95	7	MM15599
Pathway	REACTOME_RAC1_GTPASE_CYCLE	CYFIP2 ARHGEF10 PLEKHG3 SYDE2 PKN1 PKN2 IQGAP3	2.42e-04	184	95	7	M41809
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NAA15 IFT74 TBC1D5 KIAA1191 NEK4 CCDC88A ARHGEF10 CSNK1D CEP112 PLEKHG3 CSNK1E CEP95 TBC1D1 SYDE2 PLEC ZNF598 OBI1 TMCC1 USP6NL	2.60e-09	861	142	19	36931259
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PPP4R1 VPS39 IFT74 ADGRB3 NAP1L3 IFIT5 DARS1 RAD54L2 ZEB2 ZNF181 FAF1 ME3 JAK1 TRIM33 SACS ARHGEF10 GLUL GPSM2 LRPAP1 TTC17 PLEC HERPUD2 TXLNG	2.62e-09	1285	142	23	35914814
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	NRDE2 SLK RPS6KA4 ATR RPS6KA5 STK26 SLC25A25 CYFIP2 JAK1 JAK2 STK10 BCAP31 CSNK1D CSNK1E STK33 SYK PKN1 PKN2 PLEC	6.37e-09	910	142	19	36736316
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	MARS1 TMOD3 POR IFIT5 RNF213 DARS1 JAK1 BCAP31 PLEC EIF2AK2	1.70e-07	268	142	10	33024031
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	SLK NAA15 MRPS18B MARS1 STK26 TMOD3 MCM4 DARS1 SPAG9 SARNP FAF1 CYFIP2 GLUL PLEC CDC5L NME2 EIF2AK2 OBI1 IQGAP3	2.46e-07	1149	142	19	35446349
Pubmed	Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3.	RPS6KA5 JAK1 JAK2 EIF2AK2	2.58e-07	14	142	4	11350938
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CENPF SPEF2 SPTA1 COQ6 DNAH2 IFIT5 TRIM43 APOB RAD54L2 ZEB2 CYFIP2 TASOR2 TRIM43B TLK1 BCAP31 SACS GCLC CEP112 PLEC NME2 OBI1	4.37e-07	1442	142	21	35575683
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	VPS39 TBC1D5 UBXN6 SPAG9 SPG21 TRIM33 BCAP31 CSNK1D CSNK1E GLUL LRPAP1 TTC17 PKN2 CDC5L ZNF598 TXLNG USP6NL	8.37e-07	1007	142	17	34597346
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ANKRD62 RNF213 SPAG9 KIAA1191 TLK1 SACS CEP72 PLEKHG3 EEPD1 DNAH17 CDC5L TMCC1	9.49e-07	493	142	12	15368895
Pubmed	Interferons induce tyrosine phosphorylation of the eIF2alpha kinase PKR through activation of Jak1 and Tyk2.	JAK1 JAK2 EIF2AK2	1.32e-06	6	142	3	17290288
Pubmed	Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction.	SLK JAK1 JAK2	2.30e-06	7	142	3	2466296
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	VPS39 ADGRB3 SPAG9 TLK1 ARHGEF10 CEP72 TBC1D1 CDC5L	4.32e-06	225	142	8	12168954
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	CENPF MARS1 SPTA1 SMC6 RNF213 SPAG9 ZEB2 GCLC TTC17	4.79e-06	304	142	9	32235678
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	NAA15 CENPF MRPS18B STK26 SMC6 AGGF1 TMOD3 SPAG9 TASOR2 TUBGCP6 TLK1 BCAP31 CEP72 CSNK1E CDC5L OBI1 IQGAP3	5.26e-06	1155	142	17	20360068
Pubmed	A human MAP kinase interactome.	RPS6KA5 MAP3K5 TLK1 CCDC88A CEP95 GLUL LRPAP1 PLEC ZBTB18 TXLNG OBI1	5.46e-06	486	142	11	20936779
Pubmed	Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins.	RPS6KA4 RPS6KA5 SYK	5.50e-06	9	142	3	20362473
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	SLK ATR VPS39 COQ6 SMC6 RNF213 APOB SPAG9 JAK1 JAK2 BCAP31 TMTC4 GCLC ANKIB1 PKN1 OBI1	7.51e-06	1061	142	16	33845483
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	SLK NAA15 MRPS18B TBC1D5 DNAH2 ADGRB3 NME2P1 MCM4 ZNF804A CYFIP2 BCAP31 PLEC NME2 TXLNG	1.05e-05	847	142	14	35235311
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	IFT74 TBC1D5 KIAA1191 CCDC88A CSNK1D CSNK1E CEP95 TBC1D1 TTC17 MINDY4 PLEC ZNF598 TXLNG ELL	1.13e-05	853	142	14	28718761
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	NAA15 MARS1 STK26 MCM4 DARS1 SPAG9 FAF1 TRIM33 BCAP31 PKN2 PLEC CDC5L	1.31e-05	638	142	12	33239621
Pubmed	Molecular cloning of the mouse APS as a member of the Lnk family adaptor proteins.	JAK1 JAK2 SYK	1.43e-05	12	142	3	10872802
Pubmed	Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.	RPS6KA5 JAK1 JAK2	1.43e-05	12	142	3	12576423
Pubmed	A directed protein interaction network for investigating intracellular signal transduction.	AMPH RPS6KA5 MARS1 UBXN6 TMOD3 POR DARS1 SPAG9 KIAA1191 SARNP FAF1 STK16 CSNK1D CSNK1E PKN1 PKN2	1.53e-05	1124	142	16	21900206
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	RNF213 SACS CSNK1D CSNK1E PLEC	1.55e-05	76	142	5	27542412
Pubmed	Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for JAK/STAT pathway inhibition in myeloma patients.	JAK1 JAK2	1.66e-05	2	142	2	28645562
Pubmed	The Ste20 group kinases as regulators of MAP kinase cascades.	SLK STK26	1.66e-05	2	142	2	11316611
Pubmed	The role of mitogen- and stress-activated protein kinase 1 and 2 in chronic skin inflammation in mice.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	21166721
Pubmed	CK1δ and CK1ε are components of human 40S subunit precursors required for cytoplasmic 40S maturation.	CSNK1D CSNK1E	1.66e-05	2	142	2	24424021
Pubmed	Important scaffold function of the Janus kinase 2 uncovered by a novel mouse model harboring a Jak2 activation-loop mutation.	JAK1 JAK2	1.66e-05	2	142	2	24169825
Pubmed	Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies.	JAK1 SYK	1.66e-05	2	142	2	30333224
Pubmed	Sesquiterpene dimmer (DSF-27) inhibits the release of neuroinflammatory mediators from microglia by targeting spleen tyrosine kinase (Syk) and Janus kinase 2 (Jak2): Two major non-receptor tyrosine signaling proteins involved in inflammatory events.	JAK2 SYK	1.66e-05	2	142	2	24486434
Pubmed	The TGF-β signaling modulators TRAP1/TGFBRAP1 and VPS39/Vam6/TLP are essential for early embryonic development.	VPS39 TGFBRAP1	1.66e-05	2	142	2	20961651
Pubmed	Regulation of casein kinase I epsilon and casein kinase I delta by an in vivo futile phosphorylation cycle.	CSNK1D CSNK1E	1.66e-05	2	142	2	9632646
Pubmed	Characterization of the human nm23-H2 promoter region and localization of the microsatellite D17S396.	NME2P1 NME2	1.66e-05	2	142	2	7488060
Pubmed	Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors.	JAK1 JAK2	1.66e-05	2	142	2	21393331
Pubmed	Characterization of the cellular action of the MSK inhibitor SB-747651A.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	21970321
Pubmed	Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects.	JAK1 JAK2	1.66e-05	2	142	2	25977345
Pubmed	The Janus kinases inhibitor AZD1480 attenuates growth of small cell lung cancers in vitro and in vivo.	JAK1 JAK2	1.66e-05	2	142	2	24158701
Pubmed	p38{alpha} MAP kinase controls IL-17 synthesis in vogt-koyanagi-harada syndrome and experimental autoimmune uveitis.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	20164464
Pubmed	Double-stranded RNA-activated protein kinase interacts with apoptosis signal-regulating kinase 1. Implications for apoptosis signaling pathways.	MAP3K5 EIF2AK2	1.66e-05	2	142	2	12473108
Pubmed	SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.	JAK1 JAK2	1.66e-05	2	142	2	33827897
Pubmed	The forced swimming-induced behavioural immobility response involves histone H3 phospho-acetylation and c-Fos induction in dentate gyrus granule neurons via activation of the N-methyl-D-aspartate/extracellular signal-regulated kinase/mitogen- and stress-activated kinase signalling pathway.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	18513320
Pubmed	HCV-induced PKR activation is stimulated by the mitogen- and stress-activated protein kinase MSK2.	RPS6KA4 EIF2AK2	1.66e-05	2	142	2	21385567
Pubmed	Novel roles of PRK1 and PRK2 in cilia and cancer biology.	PKN1 PKN2	1.66e-05	2	142	2	32127582
Pubmed	Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies.	JAK1 JAK2	1.66e-05	2	142	2	29508247
Pubmed	A role of mitogen and stress-activated protein kinase 1/2 in survival of lipopolysaccharide-stimulated RAW 264.7 macrophages.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	15681159
Pubmed	Mitogen- and stress-activated protein kinase 1 mediates cAMP response element-binding protein phosphorylation and activation by neurotrophins.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	15128846
Pubmed	Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice.	JAK1 JAK2	1.66e-05	2	142	2	27222478
Pubmed	Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.	JAK1 JAK2	1.66e-05	2	142	2	27903500
Pubmed	Two members of the JAK family of protein tyrosine kinases map to chromosomes 1p31.3 and 9p24.	JAK1 JAK2	1.66e-05	2	142	2	1581631
Pubmed	Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severity.	JAK1 JAK2	1.66e-05	2	142	2	19887489
Pubmed	Focus on molecules: Wnt8b: a suppressor of early eye and retinal progenitor formation.	WNT8B SIX3	1.66e-05	2	142	2	21219900
Pubmed	Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2.	JAK1 JAK2	1.66e-05	2	142	2	35382859
Pubmed	Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	36812480
Pubmed	Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	21314333
Pubmed	Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.	CSNK1D CSNK1E	1.66e-05	2	142	2	19043076
Pubmed	Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer.	PKN1 PKN2	1.66e-05	2	142	2	26296974
Pubmed	Activity and substrate specificity of the murine STK2 Serine/Threonine kinase that is structurally related to the mitotic regulator protein NIMA of Aspergillus nidulans.	SLK NEK4	1.66e-05	2	142	2	10529384
Pubmed	Mitogen and stress-activated kinases 1/2 regulate ischemia-induced hippocampal progenitor cell proliferation and neurogenesis.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	25451279
Pubmed	Mitogen- and stress-activated protein kinase 1 modulates photic entrainment of the suprachiasmatic circadian clock.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	23127194
Pubmed	Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells.	JAK1 JAK2	1.66e-05	2	142	2	22684105
Pubmed	Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.	CSNK1D CSNK1E	1.66e-05	2	142	2	25404202
Pubmed	Cloning and expression patterns of two members of a novel protein-kinase-C-related kinase family.	PKN1 PKN2	1.66e-05	2	142	2	7851406
Pubmed	The Chromatin Modifier MSK1/2 Suppresses Endocrine Cell Fates during Mouse Pancreatic Development.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	27973548
Pubmed	Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase.	JAK1 JAK2	1.66e-05	2	142	2	1848670
Pubmed	MSK activation and physiological roles.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	18508628
Pubmed	Exome sequencing: an efficient diagnostic tool for complex neurodegenerative disorders.	APOB SACS	1.66e-05	2	142	2	23043354
Pubmed	Preclinical evaluation of JAK1/2 inhibition by ruxolitinib in a murine model of chronic graft-versus-host disease.	JAK1 JAK2	1.66e-05	2	142	2	33811972
Pubmed	Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis.	JAK1 JAK2	1.66e-05	2	142	2	29263442
Pubmed	Mitogen- and stress-activated kinases regulate progenitor cell proliferation and neuron development in the adult dentate gyrus.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	23020821
Pubmed	Accelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	26611568
Pubmed	An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disorders.	CSNK1D CSNK1E	1.66e-05	2	142	2	22981886
Pubmed	VPS39-deficiency observed in type 2 diabetes impairs muscle stem cell differentiation via altered autophagy and epigenetics.	VPS39 TGFBRAP1	1.66e-05	2	142	2	33893273
Pubmed	Mitogen and Stress-Activated Kinases 1 and 2 Mediate Endothelial Dysfunction.	RPS6KA4 RPS6KA5	1.66e-05	2	142	2	34445361
Pubmed	Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry.	RPS6KA4 STK10 CSNK1D CSNK1E PKN1	1.76e-05	78	142	5	17192257
Pubmed	Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism.	RPS6KA5 JAK1 JAK2	1.85e-05	13	142	3	14551213
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	CCDC73 MARS1 SPEF2 RNF213 CEP112 CEP95 IQGAP3	2.49e-05	208	142	7	33230847
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	SLK STK26 TMOD3 MCM4 PKN2 CDC5L OBI1	3.07e-05	215	142	7	35973513
Pubmed	A high-throughput candidate gene mutation screen in lymphoproliferative and myeloproliferative neoplasias.	JAK1 JAK2 SYK	3.59e-05	16	142	3	19464057
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	STK10 CSNK1D CEP95 PKN2 PLEC ZNF598 TXLNG IQGAP3	3.61e-05	302	142	8	30561431
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	RPS6KA4 MRPS18B MARS1 TMOD3 MCM4 DARS1 APOB FAF1 CCDC59 PLEKHG3 PLEC CDC5L EIF2AK2 USP6NL	3.65e-05	949	142	14	36574265
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	PMS1 NAA15 MRPS18B POR DNAJC27 TUBGCP6 BCAP31 CCDC88A SACS ARHGEF10 CSNK1E LRPAP1 TTC17 PKN2 CDC5L TXLNG TMCC1 USP6NL	3.77e-05	1487	142	18	33957083
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MARS1 TBC1D5 RNF213 ZC4H2 FAF1 TASOR2 JAK2 STK10 TLK1 CSNK1D PLEKHG3 TBC1D1 TGFBRAP1 EEPD1 ANKIB1 PKN1 TTC17 TMCC1	3.83e-05	1489	142	18	28611215
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	NAA15 CENPF MRPS18B POR RNF213 SPAG9 KIAA1191 SLC25A25 BCAP31 MIGA2 CSNK1D CSNK1E TTC17 MINDY4 NME2 ZNF598 EIF2AK2 TMCC1	4.07e-05	1496	142	18	32877691
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	MARS1 TMOD3 POR MCM4 DARS1 CCDC88A CEP72 CDC5L ELL	4.11e-05	399	142	9	37536630
Pubmed	Identification of NPM-ALK interacting proteins by tandem mass spectrometry.	CENPF SMC6 MAP3K5 JAK2	4.14e-05	47	142	4	14968112
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NAA15 MARS1 MCM4 DARS1 RAD54L2 SARNP ZEB2 TRIM33 STK10 TLK1 BCAP31 SYK NCOA1 NME2 TXLNG	4.82e-05	1103	142	15	34189442
Pubmed	Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis.	PKN1 PKN2	4.95e-05	3	142	2	17332740
Pubmed	Differential regulation of mitogen- and stress-activated protein kinase-1 and -2 (MSK1 and MSK2) by CK2 following UV radiation.	RPS6KA4 RPS6KA5	4.95e-05	3	142	2	19933278
Pubmed	Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia.	JAK1 JAK2	4.95e-05	3	142	2	21537335
Pubmed	Serine/Threonine kinase 16 phosphorylates STAT3 and confers a JAK2-Inhibition resistance phenotype in triple-negative breast cancer.	STK16 JAK2	4.95e-05	3	142	2	38723720
Pubmed	Progesterone activates Janus Kinase 1/2 and activators of transcription 1 (JAK1-2/STAT1) pathway in human spermatozoa.	JAK1 JAK2	4.95e-05	3	142	2	22748021
Pubmed	Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.	JAK1 JAK2	4.95e-05	3	142	2	17550976
Pubmed	Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase.	JAK1 JAK2	4.95e-05	3	142	2	9548458
Pubmed	Structural organization and chromosomal mapping of JAK3 locus.	JAK1 JAK2	4.95e-05	3	142	2	8934548
Pubmed	Foot-and-mouth disease virus structural protein VP3 degrades Janus kinase 1 to inhibit IFN-γ signal transduction pathways.	JAK1 JAK2	4.95e-05	3	142	2	26901336
Pubmed	Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450.	CSNK1D CSNK1E	4.95e-05	3	142	2	12270714
Pubmed	Protein kinase N2 mediates flow-induced endothelial NOS activation and vascular tone regulation.	PKN1 PKN2	4.95e-05	3	142	2	34499618
Pubmed	Cdc5L interacts with ATR and is required for the S-phase cell-cycle checkpoint.	ATR CDC5L	4.95e-05	3	142	2	19633697
Pubmed	Induction of Jak/STAT signaling by activation of the type 1 TNF receptor.	JAK1 JAK2	4.95e-05	3	142	2	9510175
Interaction	UBXN6 interactions	PMS1 RPS6KA4 VPS39 STK26 UBXN6 POR FAF1 CYFIP2 MAP3K5 TUBGCP6 ARHGEF10 PKN2 EIF2AK2 IQGAP3	5.31e-08	325	138	14	int:UBXN6
Interaction	YWHAE interactions	TBC1D5 STK26 TMOD3 FAF1 MAP3K5 NEK4 JAK1 JAK2 TLK1 CCDC88A KCNH2 CEP112 PLEKHG3 CSNK1E CEP95 TBC1D1 SYDE2 STK33 TTC17 MAP3K15 MINDY4 CDC5L ZNF598 TMCC1 USP6NL	1.28e-06	1256	138	25	int:YWHAE
Interaction	SYDE2 interactions	CSNK1D PLEKHG3 SYDE2 LRPAP1 PLEC	1.09e-05	43	138	5	int:SYDE2
Interaction	YWHAH interactions	RPS6KA4 IFT74 TBC1D5 KIAA1191 FAF1 CYFIP2 MAP3K5 CCDC88A CSNK1D KCNH2 CEP112 PLEKHG3 CSNK1E CEP95 TBC1D1 SYDE2 NCOA1 MAP3K15 PLEC TMCC1 USP6NL	1.95e-05	1102	138	21	int:YWHAH
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	IFIT5 TMTC4 TTC29 GPSM2 TTC17	1.66e-04	115	81	5	769
GeneFamily	C2 domain containing protein kinases	PKN1 PKN2	8.72e-04	10	81	2	835
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM43 TRIM43B TRIM33 TRIM55	8.73e-04	95	81	4	59
GeneFamily	Mitogen-activated protein kinase-activated protein kinases	RPS6KA4 RPS6KA5	1.06e-03	11	81	2	1156
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	JAK1 JAK2 MYO15A	1.46e-03	50	81	3	1293
GeneFamily	Ring finger proteins	RNF213 TRIM43 TRIM43B TRIM33 TRIM55 OBI1	1.47e-03	275	81	6	58
GeneFamily	UBX domain containing	UBXN6 FAF1	1.50e-03	13	81	2	364
GeneFamily	Dyneins, axonemal	DNAH2 DNAH17	2.58e-03	17	81	2	536
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	MAP3K5 MAP3K15	5.13e-03	24	81	2	654
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	PMS1 AMPH SLK ATR CENPF SPAG9 ZNF804A ZEB2 NEK4 TRIM33 STK10 TLK1 SACS ARHGEF10 SLC20A2 NCOA1 PKN2 ZBTB18 TMCC1	1.79e-07	856	141	19	M4500
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	SLK CTNNAL1 NAA15 ATR IFT74 SMC6 NAP1L3 AGGF1 TASOR2 TRIM33 CCDC59 CCDC88A SACS CEP112 CDC5L OBI1	5.26e-07	656	141	16	M18979
Coexpression	FINETTI_BREAST_CANCERS_KINOME_GRAY	SLK NEK4 TRIM33 TLK1	1.05e-06	15	141	4	M9693
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	RPS6KA4 IFT74 MRPS18B MARS1 TBC1D5 STK26 MCM4 DARS1 SPAG9 FAF1 CYFIP2 MAP3K5 JAK2 TRIM33 CCDC59 SACS CSNK1D TBC1D1 GLUL SYK ZBTB18	2.25e-06	1215	141	21	M41122
Coexpression	SESTO_RESPONSE_TO_UV_C5	PPP4R1 SLK TLK1 PKN2 EIF2AK2	4.82e-06	46	141	5	M1470
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	PMS1 ATP6V1C1 NAA15 ATR CENPF SMC6 AGGF1 MCM4 FAM200B FAF1 TLK1 CCDC88A GPSM2 IQGAP3	1.04e-05	644	141	14	M10501
Coexpression	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP	SMC6 PCED1B ARHGEF10 KCNH2 TBC1D1 NCOA1 ZBTB18 TMCC1	1.33e-05	200	141	8	M9205
Coexpression	ZHENG_BOUND_BY_FOXP3	AMPH TBC1D5 SPEF2 AGGF1 MAP3K5 JAK1 STK10 TLK1 ARHGEF10 HERPUD2 OBI1 USP6NL	1.69e-05	498	141	12	M1741
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	PPP4R1 RPS6KA5 UBXN6 NAP1L3 DNAJC27 SPAG9 JAK1 CSNK1D CSNK1E CEP95 PCIF1 NCOA1 LRPAP1 PKN2	1.91e-05	680	141	14	M41089
Coexpression	ZHENG_BOUND_BY_FOXP3	AMPH TBC1D5 SPEF2 AGGF1 MAP3K5 JAK1 STK10 TLK1 ARHGEF10 HERPUD2 OBI1 USP6NL	2.01e-05	507	141	12	MM1030
Coexpression	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	IFT74 SPEF2 DNAJC27 AK7 ADGB NEK4 ROPN1L CEP112 TTC29 CCDC74A TMCC1	5.08e-05	471	141	11	M3062
Coexpression	GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN	RPS6KA5 TMOD3 GLUL NCOA1 TTC17 PLEC HERPUD2	5.59e-05	180	141	7	M8906
Coexpression	DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS	ZNF487 IFT74 SPEF2 DNAH2 AK7 ADGB NEK4 MAPRE3 ROPN1L STK33 TTC29 CCDC74A MINDY4	7.90e-05	678	141	13	M40124
Coexpression	GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	ATP6V1C1 CTNNAL1 SPAG9 STK10 CCDC59 SYDE2 ZNF598	9.24e-05	195	141	7	M3145
Coexpression	GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	NAA15 MRPS18B MCM4 SIX3 CCDC59 CEP72 GPSM2	9.54e-05	196	141	7	M7551
Coexpression	GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN	SLK TBC1D5 STK26 TMOD3 RNF213 JAK1 STK10	1.05e-04	199	141	7	M3177
Coexpression	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP	CTNNAL1 UBXN6 SLC25A25 TBC1D1 ANKIB1 NCOA1 EIF2AK2	1.08e-04	200	141	7	M3614
Coexpression	GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	MAP3K5 TLK1 PLEKHG3 TGFBRAP1 PCIF1 SYK AFG1L	1.08e-04	200	141	7	M8497
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	PMS1 NAA15 ATR CENPF SMC6 TMOD3 MCM4 FAF1 TLK1 CCDC88A CSNK1D PLEC CDC5L	1.45e-04	721	141	13	M10237
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	ATP6V1C1 SLK RPS6KA5 POR SPAG9 ZEB2 TRIM33 STK10 GCLC CEP112 NCOA1 TTC17 TMCC1 ELL	1.45e-04	822	141	14	M6782
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	SLK ATR RPS6KA5 SPEF2 AGGF1 RNF213 DARS1 ZEB2 CYFIP2 PCED1B JAK1 TRIM33 STK10 TLK1 CCDC88A SACS TBC1D1 NCOA1 HERPUD2 ELL	1.47e-04	1492	141	20	M40023
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ZNF487 SPEF2 AK7 ADGB MAPRE3 ROPN1L STK33 TTC29 CCDC74A	1.32e-08	197	140	9	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1\|bone_marrow / Manually curated celltypes from each tissue	CENPF DNAH2 MCM4 CCDC88A SYK GPSM2 PLEC IQGAP3	1.12e-07	181	140	8	ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c
ToppCell	Multiciliated\|World / shred by cell class for nasal brushing	ZNF487 SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	1.56e-07	189	140	8	34b110aef839376228c5a403a6b5047a945f472b
ToppCell	cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	1.98e-07	195	140	8	d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IFT74 SPEF2 SIX3 AK7 ADGB ROPN1L STK33 TTC29	1.98e-07	195	140	8	d211a836cf711fdb91b10d512f09d462be937cc5
ToppCell	cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	1.98e-07	195	140	8	e7f069f557a59ee7b502ff82ad4c9f47fa619ba8
ToppCell	proximal-Epithelial-Ciliated\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.31e-07	199	140	8	9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76
ToppCell	proximal-3-Epithelial-Ciliated\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.31e-07	199	140	8	1188afad6fd5f01f9aeba225f611f38b237dd2c9
ToppCell	proximal-Epithelial-Ciliated-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.31e-07	199	140	8	2e8ace105c4e2405baa06d953e52888b54e2d055
ToppCell	Biopsy_Control_(H.)-Epithelial-Ciliated\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.40e-07	200	140	8	9ae434c78e08adf95da49c85616e3ca72d1227bf
ToppCell	Biopsy_Other_PF-Epithelial-Ciliated\|Biopsy_Other_PF / Sample group, Lineage and Cell type	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.40e-07	200	140	8	721371698bce8890853fb6b6b01a2c20293b39e9
ToppCell	Biopsy_IPF-Epithelial-Ciliated\|Biopsy_IPF / Sample group, Lineage and Cell type	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.40e-07	200	140	8	bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8
ToppCell	Ciliated_cells-A-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.01e-06	185	140	7	d77ca57b02125a3a57a37f4aed20c89803b7d551
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	2.01e-06	185	140	7	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPEF2 DNAH2 AK7 ADGB STK33 TTC29 CCDC74A	2.08e-06	186	140	7	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	tumor_Lung-Epithelial_cells-tS3\|tumor_Lung / Location, Cell class and cell subclass	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.24e-06	188	140	7	26326b4e298e33f9ba393fc632238aa8c54b1ea3
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPEF2 DNAH2 AK7 ADGB ROPN1L TTC29 CCDC74A	2.24e-06	188	140	7	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	(7)_Epithelial-F_(Ciliated)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.24e-06	188	140	7	9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3
ToppCell	Control-Epithelial-Ciliated\|Control / Disease state, Lineage and Cell class	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.32e-06	189	140	7	c007fccd08728db3ea99af9da91d67b9b16dabb3
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	2.32e-06	189	140	7	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.40e-06	190	140	7	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.40e-06	190	140	7	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	2.48e-06	191	140	7	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	2.48e-06	191	140	7	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	2.48e-06	191	140	7	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175\|Adult / Lineage, Cell type, age group and donor	ZNF804A ZEB2 CCDC88A FMN1 EEPD1 GLUL SYK	2.57e-06	192	140	7	733491e932350e3c216a626cc49c3cd3fe970a82
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	2.57e-06	192	140	7	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122\|Adult / Lineage, Cell type, age group and donor	ZEB2 ME3 PCED1B STK10 CCDC88A GLUL SYK	2.66e-06	193	140	7	cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	2.66e-06	193	140	7	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	2.66e-06	193	140	7	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPEF2 DNAH2 AK7 ADGB STK33 TTC29 CCDC74A	2.75e-06	194	140	7	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	Control-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.75e-06	194	140	7	958e648138676d46698090b4046cb484083ae449
ToppCell	wk_15-18-Epithelial-Proximal_epithelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.75e-06	194	140	7	b0477583301dc6d9767b667bd2f8f94fbfaa6f81
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	2.75e-06	194	140	7	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AMPH ZEB2 CCDC88A FMN1 EEPD1 GLUL SYK	2.85e-06	195	140	7	9d649ac7d2af313481069c95349efc0c68449e2b
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.85e-06	195	140	7	cfcf554b436083179dea1d6fd6e3a800ea2430fe
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC141 ZEB2 STK10 CCDC88A FMN1 GLUL SYK	2.85e-06	195	140	7	247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell	NS-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.85e-06	195	140	7	34e37cff4849696ca4ba5dd8fd2cf98fed8bc912
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SPEF2 DNAH2 AK7 ADGB MAPRE3 STK33 TTC29	2.85e-06	195	140	7	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SPEF2 DNAH2 AK7 ADGB MAPRE3 STK33 TTC29	2.85e-06	195	140	7	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SPEF2 DNAH2 AK7 ADGB STK33 TTC29 CCDC74A	2.95e-06	196	140	7	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	2.95e-06	196	140	7	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	Children_(3_yrs)-Immune\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZNF804A ZEB2 PCED1B STK10 CCDC88A GLUL SYK	3.05e-06	197	140	7	f18807124b91310fcd84238484a80ecdba684679
ToppCell	wk_20-22-Epithelial-Proximal_epithelial\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.15e-06	198	140	7	16c54b884500066ade05a406915f9569ca8abdfc
ToppCell	Immune\|World / Lineage, Cell type, age group and donor	ZNF804A ZEB2 PCED1B STK10 CCDC88A GLUL SYK	3.15e-06	198	140	7	65681b54d13c6997bd90a1c2a12314a80e964fe3
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF804A ZEB2 CCDC88A FMN1 EEPD1 GLUL SYK	3.15e-06	198	140	7	0b41b3d6c2db795320e8b65d40d85fb8b618cc34
ToppCell	medial-Epithelial-Ciliated-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.26e-06	199	140	7	526002f16bbf61cf086278d45a401cc0b0b757a8
ToppCell	distal-Epithelial-Ciliated-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.26e-06	199	140	7	2de1fe124737a6cca4b3805ab3056f9d9d7c16c7
ToppCell	medial-Epithelial-Ciliated\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.26e-06	199	140	7	a2daa42b100c422dc8c04fb7d2ebf54293eef574
ToppCell	distal-Epithelial-Ciliated\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.26e-06	199	140	7	18ca031cfe702afb9bf94e03c0f3680c38e7599e
ToppCell	medial-2-Epithelial-Ciliated\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.26e-06	199	140	7	c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7
ToppCell	distal-2-Epithelial-Ciliated\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.26e-06	199	140	7	97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	52aef65f01b06cd98056f17977efe525aee6eb6f
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	55c148238d5c80c1faa3428a917ae8075be2c145
ToppCell	Biopsy_Other_PF-Epithelial-Differentiating_Ciliated\|Biopsy_Other_PF / Sample group, Lineage and Cell type	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	f7b4581d958afbd68f9045af619aaca0ab463439
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	3.37e-06	200	140	7	31d75c26055177d656df1fbb10b764cebd61e122
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	5abd6d81e1cc354484ae693fcd708d78926e75b5
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	7cb3e3bd9e851ccb096e0a3471819471d85ebace
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SPEF2 DNAH2 AK7 ADGB ROPN1L STK33 TTC29	3.37e-06	200	140	7	e1dce91c6c531bb212002a14705e496d77ad3490
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	DNAH2 MIGA2 ARHGEF10 PLEKHG3 TBC1D1 SYDE2 TXLNG	3.37e-06	200	140	7	6b7314c425f6b40f1301dd39cc02b0436e96a2ec
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Cilia-bearing_cell\|3m / Sample Type, Dataset, Time_group, and Cell type.	ZNF487 SPEF2 AK7 ADGB ROPN1L STK33 TTC29	3.37e-06	200	140	7	0d14a950172a56b11fdebee8f4e13b0c10e0d592
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	f1a49bc818054fb0734d3b84725ee6487b034567
ToppCell	Parenchyma_COVID-19-Epithelial-TX-Ciliated\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	12bc7d95c4166d12487081a76d210b7abe5991b0
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SPEF2 DNAH2 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	ddd39b754bfaa98249d497dfb7e97ec58617a11a
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Ciliated\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SPEF2 DNAH2 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	a521cf837cadf280505ff9d7e641a205af7d6513
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPEF2 DNAH2 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	918b576fd9491d23c2bb9d663fa5fb3505cb1c7e
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	ZEB2 SIAH3 CCDC88A TMTC4 SACS HERPUD2 TMCC1	3.37e-06	200	140	7	c6bbd33bca86ac7a76a7ba704b3e141237d04549
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	8441e289377215a6877640946fe3f6de1f456502
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SPEF2 AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	3.37e-06	200	140	7	cf59110547cc66b5f4a2999735336b0309ba9b0d
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 AK7 ADGB ROPN1L STK33 TTC29	7.47e-06	148	140	6	d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 AK7 ADGB ROPN1L STK33 TTC29	7.47e-06	148	140	6	c8e93b87212f55774223caa385859c566fa1981f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 AK7 ADGB ROPN1L STK33 TTC29	9.73e-06	155	140	6	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 AK7 ADGB ROPN1L STK33 TTC29	9.73e-06	155	140	6	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	droplet-Lung-nan-21m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 SPG21 JAK2 STK10 CCDC88A TMCC1	1.17e-05	160	140	6	0b8151037b28f52a21918856a1e9336e8d5edb90
ToppCell	droplet-Lung-nan-21m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 SPG21 JAK2 STK10 CCDC88A TMCC1	1.17e-05	160	140	6	4738d0c73d8c3508e5b5beb6c61e0ad551d9b949
ToppCell	facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRP6 CCDC88A PLEKHG3 SLC20A2 EEPD1 DNAH17	1.44e-05	166	140	6	a2ce44702a0cd5fa5872cac3302d3c451205feef
ToppCell	facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRP6 CCDC88A PLEKHG3 SLC20A2 EEPD1 DNAH17	1.44e-05	166	140	6	0f641302a6b71c4badaaf20f51162bfc2386b167
ToppCell	Ciliated_cells-B-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	SPEF2 DNAH2 ADGB ROPN1L STK33 CCDC74A	2.07e-05	177	140	6	c38138fb5ad9766c2d240811210c854338cd612e
ToppCell	Children_(3_yrs)\|World / Lineage, Cell type, age group and donor	TBC1D5 CCDC141 ZNF804A PCED1B FMN1 SYK	2.13e-05	178	140	6	df2ecd3214590b914f2762db57efe780ba038db3
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNF213 ZNF804A ZEB2 CCDC88A GLUL SYK	2.42e-05	182	140	6	4234d0cc57b5266a5e03133c75c7918abe48465e
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	SPEF2 DNAH2 AK7 ADGB ROPN1L TTC29	2.42e-05	182	140	6	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	Ciliated_cells-B-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	SPEF2 DNAH2 ADGB ROPN1L STK33 CCDC74A	2.42e-05	182	140	6	e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH2 AK7 ADGB ROPN1L TTC29 CCDC74A	2.57e-05	184	140	6	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	SPEF2 DNAH2 ADGB ROPN1L STK33 CCDC74A	2.65e-05	185	140	6	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	SPEF2 DNAH2 AK7 ADGB ROPN1L TTC29	2.65e-05	185	140	6	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.73e-05	186	140	6	903af26a63ec4b1755ab5cb81dfeb8dbd14bc5db
ToppCell	Ciliated_cells-B-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH2 AK7 ADGB ROPN1L STK33 CCDC74A	2.81e-05	187	140	6	2b4262c2e7c7830a976be168cee6eeb738d4feda
ToppCell	COPD-Epithelial-Ciliated\|COPD / Disease state, Lineage and Cell class	AK7 ADGB ROPN1L STK33 TTC29 CCDC74A	2.81e-05	187	140	6	f0fd0792f6926f705d175f6e6fd480f12c7a3bd4
ToppCell	Ciliated_cells-B-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	SPEF2 AK7 ADGB ROPN1L STK33 TTC29	2.81e-05	187	140	6	6fa38dbccca36bc7a4fef46de74c6688f599f421
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH2 AK7 ADGB ROPN1L STK33 TTC29	2.81e-05	187	140	6	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	21-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	SPEF2 AK7 ROPN1L STK33 TTC29 CCDC74A	2.81e-05	187	140	6	1a2178a195d078d1963947b327c6d0d4f2f48341
ToppCell	Ciliated_cells-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	SPEF2 DNAH2 ADGB ROPN1L TTC29 CCDC74A	2.81e-05	187	140	6	bc1f33f332ac939c2425f510173430ca2ba0c3ee
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	SPEF2 DNAH2 AK7 ADGB ROPN1L TTC29	2.90e-05	188	140	6	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	SPEF2 DNAH2 AK7 ADGB ROPN1L TTC29	2.90e-05	188	140	6	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	Ciliated_cells-B-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	DNAH2 ROPN1L GCLC STK33 TTC29 CCDC74A	2.90e-05	188	140	6	606907c865bd2f11bb6474932716550f7723d858
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPEF2 DNAH2 AK7 ADGB ROPN1L TTC29	2.99e-05	189	140	6	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPEF2 DNAH2 ADGB ROPN1L TTC29 CCDC74A	2.99e-05	189	140	6	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
Disease	red blood cell density measurement	SLK ATR SPTA1 DNAH2 MCM4 ZEB2 ME3 TRIM33 FMN1 SLC20A2 PCIF1 PKN2 PLEC MYO15A	4.96e-05	880	134	14	EFO_0007978
Disease	Infiltrating duct carcinoma of female breast	RPS6KA4 ATR PKN1	1.15e-04	21	134	3	C3165106
Disease	Huntington's disease (is_implicated_in)	MAP3K5 GLUL EIF2AK2	1.52e-04	23	134	3	DOID:12858 (is_implicated_in)
Disease	X-24020 measurement	TUBGCP6 KCNH2	2.03e-04	5	134	2	EFO_0022128
Disease	amphetamine abuse (implicated_via_orthology)	MAP3K5 MAP3K15	3.03e-04	6	134	2	DOID:670 (implicated_via_orthology)
Disease	reticulocyte measurement	ATR SPTA1 DNAJC27 ZEB2 FAF1 MAP3K5 STK16 EEPD1 DNAH17 PCIF1 PKN2 EIF2AK2 ELL AFG1L	3.20e-04	1053	134	14	EFO_0010700
Disease	Adenocarcinoma of lung (disorder)	SLK ATR TRIM33 CSNK1E MAP3K15 EIF2AK2	3.68e-04	206	134	6	C0152013
Disease	disease of cellular proliferation (implicated_via_orthology)	JAK1 JAK2	4.24e-04	7	134	2	DOID:14566 (implicated_via_orthology)
Disease	nucleoside diphosphate kinase B measurement	SPAG9 NME2	4.24e-04	7	134	2	EFO_0020615
Disease	syndromic X-linked intellectual disability Najm type (implicated_via_orthology)	CSNK1D CSNK1E	4.24e-04	7	134	2	DOID:0060807 (implicated_via_orthology)
Disease	sensorineural hearing loss (is_implicated_in)	BCAP31 GPSM2 MYO15A	4.52e-04	33	134	3	DOID:10003 (is_implicated_in)
Disease	Polycythemia Vera	JAK1 JAK2	5.63e-04	8	134	2	C0032463
Disease	long QT syndrome (implicated_via_orthology)	ARHGAP36 KCNH2	8.99e-04	10	134	2	DOID:2843 (implicated_via_orthology)
Disease	renal cell carcinoma	SLK ZEB2 FAF1	9.24e-04	42	134	3	EFO_0000681
Disease	Adenocarcinoma of large intestine	PMS1 NEK4 PKN1 MAP3K15	9.78e-04	96	134	4	C1319315
Disease	insulin sensitivity measurement, glucose homeostasis measurement	KRT28 PKN2 EIF2AK2	9.90e-04	43	134	3	EFO_0004471, EFO_0006896
Disease	cerebral cavernous malformation (implicated_via_orthology)	STK26 RNF213	1.10e-03	11	134	2	DOID:0060669 (implicated_via_orthology)
Disease	Hirschsprung's disease (is_implicated_in)	WNT8B ZEB2	1.10e-03	11	134	2	DOID:10487 (is_implicated_in)
Disease	hematologic cancer (implicated_via_orthology)	JAK1 JAK2	1.55e-03	13	134	2	DOID:2531 (implicated_via_orthology)
Disease	mean corpuscular hemoglobin concentration	SLK ATR SPTA1 ZEB2 ME3 NLRP6 NEK4 TRIM33 SLC20A2 PCIF1 PKN2 MYO15A ELL	1.60e-03	1105	134	13	EFO_0004528
Disease	age at menarche	TBC1D5 DNAH2 ZNF75CP SIX3 CYFIP2 NLRP6 SEMA6D TGFBRAP1 STK33	1.61e-03	594	134	9	EFO_0004703
Disease	multiple sclerosis	RPS6KA5 SPEF2 UBXN6 JAK1 JAK2 ARHGEF10 SYDE2 SYK PLEC	1.61e-03	594	134	9	MONDO_0005301
Disease	membranous glomerulonephritis (biomarker_via_orthology)	MAP3K5 LRPAP1	1.80e-03	14	134	2	DOID:10976 (biomarker_via_orthology)
Disease	monocyte percentage of leukocytes	SPEF2 NLRP6 JAK1 JAK2 GCLC CSNK1D TBC1D1 TGFBRAP1 NCOA1 CDC5L	1.90e-03	731	134	10	EFO_0007989
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	APOB PCIF1	2.07e-03	15	134	2	EFO_0022328
Disease	vascular endothelial growth factor measurement	ATP13A4 DNAH2 CDC5L	2.13e-03	56	134	3	EFO_0004762
Disease	immature platelet measurement	PPP4R1 TBC1D5 TLK1 PLEC	2.16e-03	119	134	4	EFO_0803541
Disease	Schizoaffective disorder-bipolar type	STAB2 ZNF804A	2.36e-03	16	134	2	EFO_0009965
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOB PCIF1	2.66e-03	17	134	2	EFO_0022232
Disease	Malignant neoplasm of endometrium	PMS1 ATR	2.99e-03	18	134	2	C0007103
Disease	Carcinoma in situ of endometrium	PMS1 ATR	2.99e-03	18	134	2	C0346191
Disease	fish consumption measurement	TBC1D5 ADGRB3 TMTC4	3.12e-03	64	134	3	EFO_0010139
Disease	Chronic myeloproliferative disorder	ATR CENPF	3.33e-03	19	134	2	C1292778
Disease	Microcephaly	CENPF ZC4H2 CCDC88A	3.55e-03	67	134	3	C0025958
Disease	smoking cessation	RPS6KA4 CCDC141 ZNF804A MAPRE3 SEMA6D TTC29	3.77e-03	325	134	6	EFO_0004319
Disease	Neoplastic Cell Transformation	POR ZEB2 GCLC KCNH2	3.77e-03	139	134	4	C0007621
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	APOB PCIF1	4.06e-03	21	134	2	EFO_0022246
Disease	metabolite measurement	SPTA1 POR FAM200B TUBGCP6 STK10 KCNH2 PCIF1 HERPUD2	4.15e-03	560	134	8	EFO_0004725
Disease	Seckel syndrome	ATR CENPF	4.46e-03	22	134	2	C0265202
Disease	nucleotide measurement	SMC6 JAK1 HERPUD2	4.52e-03	73	134	3	EFO_0010513

Protein segments in the cluster

Peptide	Gene	Start	Entry
KISNIKEHLEHLLRY	PRAMEF33	276	A0A0G2JMD5
LRNEIHFFLIEKKSH	FAM200B	401	P0CF97
QLSHDLTRLKEHYEK	ARHGEF10	306	O15013
EKELQHRYADLLLEK	CDC5L	781	Q99459
EYLHSKLAHIKRLIA	ELL	596	P55199
EEYRNKLLEAEHLKL	ADGB	1621	Q8N7X0
EYRHLQHSIKEHLAK	ADGRB3	571	O60242
RVIALAYKKLENDHH	ATP13A4	656	Q4VNC1
LDHYDFLIKAHELKD	AFG1L	76	Q8WV93
HYEREALKEKTLHIE	ANKRD62	721	A6NC57
KHIYEKKAHDLQSEL	CEP112	546	Q8N8E3
YDIHFHDKKILLLEA	COQ6	56	Q9Y2Z9
KNHEHSYQLEQRLLK	ANKIB1	606	Q9P2G1
IEKLLHHTERLYQNA	AGGF1	46	Q8N302
LKQHLEHYDKIQELT	CEP72	571	Q9P209
FEHESLLLNRKDHKL	RAD54L2	946	Q9Y4B4
FLHHKEKVHEYNVLL	LRPAP1	176	P30533
EHLKRENKDLHYKLI	CCDC74A	76	Q96AQ1
NDYDILRKEKFHHLI	EEPD1	456	Q7L9B9
KLVDYDSARHHLEAL	AMPH	141	P49418
LKLQETAYHELVARH	ARHGAP36	61	Q6ZRI8
EYQAAILHLKREHKE	FMN1	721	Q68DA7
DLKKEIEILRNLYHE	JAK1	921	P23458
SLRDYLQKHKERIDH	JAK2	936	O60674
EHFLLHREGKYKDTL	KIR2DS2	56	P43631
ELKKEYNALHQRHTE	SPAG9	151	O60271
LRASEEHLKQHYIDL	NME2	41	P22392
EHLKQHYIDLKDRPF	NME2	46	P22392
IDVIHYRKTDAKRLH	MCM4	416	P33991
LEYEHLLDVKVHLEK	KRT28	371	Q7Z3Y7
AIDYHLKHLAIAQEL	GPSM2	301	P81274
KVAELVHFLLHKYRV	MAGEA9	111	P43362
HKVYVQHLLKQDREH	POR	601	P16435
LKEHLYQLLESMREH	MYO15A	1886	Q9UKN7
DEVNKAYRKLAVLLH	DNAJC27	231	Q9NZQ0
CLLHEGKVLHYRIDK	SYK	206	P43405
HKIHRDDLLEVLDMY	KCNH2	831	Q12809
KEYDRLLEEHAKLQA	BCAP31	221	P51572
LIKDHEKLELLHERQ	CCDC88A	1156	Q3V6T2
EKLHKLFSQDHLVIY	NUDT9	251	Q9BW91
HRAVYKDLVLLLQKD	PCED1B	26	Q96HM7
YLHEKHILHRDLKTQ	NEK4	121	P51957
EHARKLLEFHIQKQL	FAM205A	586	Q6ZU69
IEYIHSKNFIHRDVK	CSNK1D	116	P48730
LHIYHAVKDRHKDVL	GCLC	31	P48506
VLAVHILKARKAYEH	NRDE2	866	Q9H7Z3
HLRKTRLELLHKEYE	OBI1	86	Q5W0B1
KLESLLHRAYHLQEE	MIGA2	236	Q7L4E1
LEEIQRAHAEYLHKA	TUBGCP6	1706	Q96RT7
HLHKLGIIYRDLKLE	RPS6KA4	151	O75676
EHLHKLGIIYRDIKL	RPS6KA5	166	O75582
EETKYLRVAEALHKL	KIAA1191	141	Q96A73
HHQLKDIIEYAELKT	CYFIP2	1001	Q96F07
HLRVLNDYLEETHLK	IQGAP3	1231	Q86VI3
KAARIAIEIYLKLHD	NAA15	556	Q9BXJ9
IEKLKSLDEHYHIRV	APOB	2206	P04114
KDELERALHYLKNET	ATR	1046	Q13535
LLHEKLYELESHRDQ	IFT74	276	Q96LB3
AIHHYLEALKVKDRS	IFIT5	396	Q13325
YVEKEHLQLSHQKLS	CCDC141	321	Q6ZP82
HISLEYVKRIREKHL	PCIF1	366	Q9H4Z3
ADLLKYHADHVVLKA	CTNNAL1	406	Q9UBT7
IAEYQLRLHEAEKKH	CENPF	2696	P49454
DKEVEYHPKFRLILH	DNAH17	3516	Q9UFH2
GVDYIHSKKLIHRDL	EIF2AK2	401	P19525
KVQLHLLAKEDYHKQ	CCDC73	146	Q6ZRK6
RHDLLTTLVKKEYEH	CEP95	621	Q96GE4
KLEHEYIHNFKVLQA	MAPRE3	66	Q9UPY8
LKHQRVHGKAYDDLL	ME3	246	Q16798
HLQLKDILRKQDEYH	HERPUD2	66	Q9BSE4
DRKLLAIYLHHDESV	FAF1	371	Q9UNN5
RLLELHTYLKENAEK	DNAH2	1046	Q9P225
SGLYKDLLHKIHIDR	SLC20A2	351	Q08357
DAKLEHLIYLKNRLS	SACS	3491	Q9NZJ4
DILKLIRHHYNLKCL	PMS1	271	P54277
KYREHVLQLHARVKE	NLRP6	121	P59044
HRHKFSEELLQELKE	CPHXL	31	A0A1W2PPM1
IFKKHLLLDAERHTQ	NXPE1	381	Q8N323
LKYLHDNQIVHRDIK	MAP3K5	791	Q99683
EEIALHKYLKHRNIV	MAP3K15	696	Q6ZN16
LKYLHENQIVHRDIK	MAP3K15	761	Q6ZN16
EEAIEKLSKRHQYHI	GLUL	271	P15104
LDFKKHIEVLHYLLQ	SYDE2	1011	Q5VT97
LREVLHELYKHLDSS	ATP6V1C1	331	P21283
VKEDLAHLHFEKLER	SPEF2	166	Q9C093
LLEHKEHRYQFLEEA	TRIM33	301	Q9UPN9
NEYRKLHPVLHKEEK	TRIM43	181	Q96BQ3
HKEEKQHLERLNKEY	TRIM43	191	Q96BQ3
DALNYLHDNKIIHRD	SLK	141	Q9H2G2
IAYLHNNDIVHRDLK	STK33	226	Q9BYT3
HDFLKLLHIDKRREY	PPP4R1	726	Q8TF05
LEAIHAKGYAHRDLK	STK16	136	O75716
KQDLIHRLQAYLEEH	SARNP	31	P82979
GLDYLHSEKKIHRDI	STK26	131	Q9P289
ILKYHLLLQEIAKHF	PLEKHG3	231	A1L390
EHLKQHYIDLKDRPF	NME2P1	31	O60361
HQLLRYLLDKDEKDL	NCOA1	746	Q15788
RDLYHILENHKFTKE	SIX3	146	O95343
VLDLIHLRFQHYKAK	SIAH3	11	Q8IW03
DNLKHLYLAEEERHR	CCDC59	91	Q9P031
LKAIHDLERKYAELN	NAP1L3	126	Q99457
RALHHGIDLEKIKAY	DARS1	441	P14868
LHEHKIVYRDLKLDN	PKN1	731	Q16512
QYLHEHKIVYRDLKL	PKN2	771	Q16513
FRKLLDHLQLDKVHL	SPG21	91	Q9NZD8
EFVHYLQDHEKKLRL	SLC25A25	71	Q6KCM7
IKDRVEQIKEYHHLH	RNF213	1336	Q63HN8
HLDLAKKHYEISLQL	TMTC4	701	Q5T4D3
IHKELDHPRIVKLYD	TLK1	511	Q9UKI8
AHLKEKYHAALKVDL	WNT8B	206	Q93098
HKLHVDFRNVKLLEQ	MRPS18B	111	Q9Y676
HLVIDKRLQKEEYHT	TGFBRAP1	596	Q8WUH2
KRLQKEEYHTHLAVL	TGFBRAP1	601	Q8WUH2
HLHPEEEKYRKIKLQ	UBXN6	186	Q9BZV1
LLRFQEHHEKILNKF	USP6NL	231	Q92738
LEHVRALIKKYSDHL	TRIM55	241	Q9BYV6
DLRKVLHLEFLYKEN	MINDY4	46	Q4G0A6
CHHKRYVELTDLEQK	ROPN1L	86	Q96C74
LFYKDQLDKRDIVHL	ZBTB18	51	Q99592
DLIKHQRIHTEEKLY	ZNF75CP	306	Q92670
YFLQRHELLRKHEKE	STK10	766	O94804
FLRCLYEEKQKEHIH	TBC1D1	451	Q86TI0
KIHLAYLADLFKHLN	ZBED8	371	Q8IZ13
KISNIKEHLEHLLRY	PRAMEF10	276	O60809
IKHNEELLKRCQLHY	SMC6	696	Q96SB8
RHYEEKQKEHLDTLN	SMC6	816	Q96SB8
QKKLEHYHRKLREVE	TMCC1	296	O94876
YHVVLEEKLLKNDLH	STAB2	1201	Q8WWQ8
LAAAHHEKLKEAYAL	SPTA1	1701	P02549
KHLIKAQRHISDLYE	PLEC	191	Q15149
HYLRQQEILEKHKLI	TTC17	371	Q96AE7
YLDNDELLKHLRRDH	ZNF598	196	Q86UK7
RSQLIKEKDDIDHYL	TTC29	31	Q8NA56
NEYRKLHPVLHKEEK	TRIM43B	181	A6NCK2
HKEEKQHLERLNKEY	TRIM43B	191	A6NCK2
YALLLTEHSKKHLQE	TASOR2	656	Q5VWN6
KHDIELYMHLNRLEI	TBC1D5	311	Q92609
LKEHIKYRHEKNEEN	ZEB2	226	O60315
KVISLQLDKDHHALY	SEMA6D	486	Q8NFY4
LKKLIEQYALREEHI	TXLNG	276	Q9NUQ3
TLELQHYHQLLEKVR	MARS1	686	P56192
AKLYLHQKEHLREKL	ZNF17	111	P17021
LIEHLRIHTQEKLYE	ZNF181	336	Q2M3W8
KLLDIGHALQYIKEH	ZNF487	266	B1APH4
REHLLSYLEKEALEH	TMOD3	66	Q9NYL9
KHEQALFIYVHILKD	VPS39	701	Q96JC1
INSYDHAHKQRLKEL	ZNF804A	76	Q7Z570
RLHDEYKPLKEHVDA	ZC4H2	96	Q9NQZ6
IEYIHSKNFIHRDVK	CSNK1E	116	P49674
YKLHHIQLKDVISEA	AK7	391	Q96M32